Press releases
Welcome to the press section. If you want to be included in our media database, please send us an email.
Filter Press releases:
![Cover Annual Report 2020/21 BRAIN Biotech AG](https://www.brain-biotech.com/sized/press/2022/01/10863227/Cover_Annual-Report_2020-21_BRAINbiotech_65b9cd00a9f1b1197b77a4f5ff7ae816.jpg 794w 595h, https://www.brain-biotech.com/sized/press/2022/01/10863227/Cover_Annual-Report_2020-21_BRAINbiotech_1c09d3e61e0aab4fdcf773d485cd6c6b.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2022/01/10863227/Cover_Annual-Report_2020-21_BRAINbiotech_990681f3e4c281359830d625421e9993.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2022/01/10863227/Cover_Annual-Report_2020-21_BRAINbiotech_47f4e309458cc03ff4514e0aa910c8e4.jpg 400w 300h)
BRAIN Biotech AG publishes Annual Report for FY 2020/21
BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)
BRAIN and SAMS apply BEC gene-editing technology to Omega-3 Compounds from Marine Organisms
BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives
BRAIN Biotech AG resolves on a cash capital increase from authorised capital
![Screenshots from BRAIN Biotech´s CMD presentations](https://www.brain-biotech.com/sized/press/2021/09/10816463/CMD-2021-BRAIN-Biotech-AG_e64595890892ef90bc6e36e9357f6ced.jpeg 954w 716h, https://www.brain-biotech.com/sized/press/2021/09/10816463/CMD-2021-BRAIN-Biotech-AG_b21614607ad61004f3e3f4cc9e45162c.jpeg 768w 576h, https://www.brain-biotech.com/sized/press/2021/09/10816463/CMD-2021-BRAIN-Biotech-AG_e87bcc7de5563807162e22d72e08cb4c.jpeg 576w 432h, https://www.brain-biotech.com/sized/press/2021/09/10816463/CMD-2021-BRAIN-Biotech-AG_7aaea36e1c69e77199618dc527ff476a.jpeg 400w 300h)